Institute of Cardiovascular Research, Royal Holloway, University of London, Egham, Surrey, UK.
Department of Cardiology, Ashford and St Peter's NHS Foundation Trust, Chertsey, Surrey, UK.
Andrology. 2024 Feb;12(2):297-315. doi: 10.1111/andr.13484. Epub 2023 Jun 28.
Obesity-induced hypogonadism, which manifests as erectile dysfunction and a lack of libido, is a less visible and under-recognized obesity-related disorder in men.
We examined the impact of weight loss on total (TT) and free testosterone (FT) levels, and constructed nomograms to provide an easy-to-use visual aid for clinicians.
Meta-analysis was conducted using RevMan (v5.3) and expressed in standardized mean differences (SMD) for testosterone. Parallel-scale nomograms were constructed from baseline and target body mass index values to estimate the gain in testosterone.
In total, 44 studies were included, comprising 1,774 participants and 2,159 datasets, as some studies included several datasets at different time points. Weight loss was controlled by low calorie diet (LCD) in 19 studies (735 participants, 988 datasets), by bariatric surgery (BS) in 26 studies (1,039 participants, 1,171 datasets), and by both in one study. The median follow-up was 26 weeks (interquartile range = 12-52). The range of baseline mean age was 21-68 yr, BMI: 26.2-71.2 kg/m , TT: 7-20.2 nmol/L and FT: 140-583 pmol/L. TT levels increased after weight loss by LCD: SMD (95%CI) = 2.5 nmol/L (1.9-3.1) and by BS: SMD = 7.2 nmol/L (6.0-8.4); the combined TT gain was 4.8 nmol/L (3.9-5.6). FT levels increased after weight reduction by LCD: SMD = 19.9 pmol/L (7.3-32.5) and by BS: SMD = 58.0 pmol/L (44.3-71.7); the combined gain was 42.2 pmol/L (31.4-52.9). Greater amounts of total and free testosterone could be gained by weight loss in men with higher baseline BMI, or lower levels of SHBG, TT and FT, while gain in TT was relatively greater in older and FT in younger age. Age-stratified nomograms revealed that compared to older men (> 40 yr), younger men (≤ 40 yr) gained less TT but more FT for a given weight loss.
Both TT and FT levels increased after weight loss, relatively greater with higher baseline BMI, or lower levels of SHBG, TT and FT. Nomograms constructed from a large number of participants with a wide range of BMI and testosterone values provide an evidence-based and simple-to-use tool in clinical practice.
肥胖导致的性腺功能减退症表现为勃起功能障碍和性欲减退,是男性中一种不太明显且未被充分认识的与肥胖相关的疾病。
我们研究了体重减轻对总睾酮(TT)和游离睾酮(FT)水平的影响,并构建了列线图,为临床医生提供了一种易于使用的可视化工具。
使用 RevMan(v5.3)进行荟萃分析,并以睾酮的标准化均数差(SMD)表示。根据基线和目标体重指数值构建平行比例列线图,以估计睾酮的增加量。
共有 44 项研究纳入 1774 名参与者和 2159 组数据,其中一些研究在不同时间点包含了多个数据集。19 项研究(735 名参与者,988 组数据)采用低热量饮食(LCD)控制体重减轻,26 项研究(1039 名参与者,1171 组数据)采用减重手术(BS)控制体重减轻,1 项研究同时采用了这两种方法。中位随访时间为 26 周(四分位间距 12-52 周)。基线平均年龄范围为 21-68 岁,BMI:26.2-71.2kg/m2,TT:7-20.2nmol/L,FT:140-583pmol/L。体重减轻后,LCD 组 TT 水平升高:SMD(95%CI)=2.5nmol/L(1.9-3.1),BS 组 TT 水平升高:SMD=7.2nmol/L(6.0-8.4);联合 TT 增加量为 4.8nmol/L(3.9-5.6)。体重减轻后,LCD 组 FT 水平升高:SMD=19.9pmol/L(7.3-32.5),BS 组 FT 水平升高:SMD=58.0pmol/L(44.3-71.7);联合 FT 增加量为 42.2pmol/L(31.4-52.9)。基线 BMI 较高或 SHBG、TT 和 FT 水平较低的男性,体重减轻可导致更多的 TT 和 FT 增加,而 TT 增加量相对较大,FT 增加量相对较大。年龄分层列线图显示,与年龄较大的男性(>40 岁)相比,年龄较小的男性(≤40 岁)在相同体重减轻量下 TT 增加较少,但 FT 增加较多。从大量具有广泛 BMI 和睾酮值的参与者中构建的列线图为临床实践提供了一种基于证据且易于使用的工具。